Essential-3 ERL

ERL3 ERL3 is a triple agonist research compound targeting GLP-1, GIP, and glucagon receptor pathways, developed for use in preclinical and in vitro research settings. As a multi-receptor agonist, ERL3 is of particular interest to researchers studying metabolic regulation, energy expenditure, and receptor cross-talk in models of weight and glucose homeostasis. Research Applications Commonly used in studies examining: Comparative receptor agonism across GIP-1, GIP, and glucagon pathways Metabolic and energy expenditure modeling Structure-activity relationship (SAR) studies in incretin-based research Purity & Documentation Each batch is independently verified via third-party HPLC/MS analysis. Certificates of Analysis (COA) are available for every lot, confirming purity and identity prior to shipment. For Research Use Only. Not for human or veterinary use. Not intended for diagnostic or therapeutic use. Sold exclusively for laboratory and research purposes to qualified researchers and institutions.

Select an option

• COA available for qualifying batches
• Fast U.S. fulfillment with tracking
• Secure checkout